why choose us

300×250 Ad Slot

Research Article: Diosbulbin C, a novel active ingredient in Dioscorea bulbifera L. extract, inhibits lung cancer cell proliferation by inducing G0/G1 phase cell cycle arrest

Date Published: 2023-12-04

Abstract:
Despite the critical progress of non-small cell lung cancer (NSCLC) therapeutic approaches, the clinical outcomes remain considerably poor. The requirement of developing novel therapeutic interventions is still urgent. In this study, we showed for the first time that diosbulbin C, a natural diterpene lactone component extracted from traditional Chinese medicine Dioscorea bulbifera L., possesses high anticancer activity in NSCLC.

Introduction:
Despite the decline in cancer death rate in recent years due to earlier detection and treatment advances, lung cancer (LC) still runs the leading cause of cancer-associated mortality worldwide [1]. LC is pathologically classified into small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). The latter accounts for the large majority of all diagnosed LC cases (~?85%) [2]. Currently, treatments of NSCLC in the clinic mainly include surgery, radio-/chemo-therapy, targeted therapy, immunotherapy, and…

Read more

300×250 Ad Slot